General Information of Drug (ID: DMBGRGB)

Drug Name
GSK3888550A
Indication
Disease Entry ICD 11 Status REF
Respiratory syncytial virus infection 1C80 Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DI1S4K

References

1 ClinicalTrials.gov (NCT04126213) Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants. U.S. National Institutes of Health.